National Bank Of Canada Ginkgo Bioworks Holdings, Inc. Transaction History

National Bank Of Canada

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.06 - $1.67 $8,150 - $12,840	7,689 Added 25.07%	38,361 $44,000
Q4 2023 Feb 06, 2024	BUY	$1.26 - $1.79 $22,680 - $32,220	18,000 Added 142.05%	30,672 $51,000
Q3 2023 Oct 10, 2023	SELL	$1.61 - $2.54 $8,050 - $12,700	-5,000 Reduced 28.29%	12,672 $22,000
Q2 2023 Jul 26, 2023	BUY	$1.14 - $1.95 $854 - $1,462	750 Added 4.43%	17,672 $32,000
Q1 2023 Apr 12, 2023	SELL	$1.2 - $2.19 $114,840 - $209,583	-95,700 Reduced 84.97%	16,922 $22,000
Q4 2022 Jan 24, 2023	BUY	$1.63 - $3.52 $10,467 - $22,605	6,422 Added 6.05%	112,622 $0
Q3 2022 Oct 13, 2022	BUY	$0.73 - $3.74 $55,169 - $282,650	75,575 Added 246.78%	106,200 $331,000
Q2 2022 Jul 28, 2022	SELL	$2.2 - $4.2 $272,580 - $520,380	-123,900 Reduced 80.18%	30,625 $73,000
Q1 2022 May 05, 2022	BUY	$2.83 - $8.69 $435,820 - $1.34 Million	154,000 Added 29333.33%	154,525 $623,000
Q4 2021 Jan 24, 2022	BUY	$8.31 - $14.92 $4,362 - $7,833	525 New	525 $4,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.